NASDAQ: CLGN
Collplant Biotechnologies Ltd Stock Ownership - Who owns Collplant Biotechnologies?

Insider buying vs selling

Have Collplant Biotechnologies Ltd insiders been buying or selling?

No trades
There has been no insiders buying vs selling in the past 12 months.

Be the first to know when CLGN insiders and whales buy or sell their stock.

CLGN Shareholders

What type of owners hold Collplant Biotechnologies Ltd stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Villere St Denis J Co LLC4.21%607,300$189.48kInstitution
Pinnacle Associates Ltd3.81%550,229$171.67kInstitution
Hugh M. Evans2.29%330,554$103.13kInsider
Brown Advisory Inc0.82%118,731$37.04kInstitution
Yehiel Tal0.55%80,000$24.96kInsider
Armistice Capital LLC0.44%64,000$19.97kInstitution
Eran Rotem0.42%60,000$18.72kInsider
Pathstone Holdings LLC0.40%57,000$17.78kInstitution
Jasmine Seror0.31%45,000$14.04kInsider
Bar Berta Abelis0.28%40,000$12.48kInsider

1 of 3

CLGN vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
CLGN10.60%4.63%
ELAB0.27%99.73%
CANF5.28%0.00%
TCRT0.45%99.55%Net BuyingNet Buying
MBIO6.70%13.37%Net Selling

Collplant Biotechnologies Stock Ownership FAQ

Who owns Collplant Biotechnologies?

Collplant Biotechnologies (NASDAQ: CLGN) is owned by 10.60% institutional shareholders, 4.63% Collplant Biotechnologies insiders, and 84.77% retail investors. Hugh M. Evans is the largest individual Collplant Biotechnologies shareholder, owning 330,554.00 shares representing 2.29% of the company. Hugh M. Evans's Collplant Biotechnologies shares are currently valued at $99.17k.

If you're new to stock investing, here's how to buy Collplant Biotechnologies stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.